The Telomerase Activity after LOw and Moderate Intensity Exercise (TALOMIE) trial in young (18-45 years) and older (65-80 years) healthy adults

niversity of Southern Queensland0 个研究点目标入组 24 人开始时间: 2021年11月12日最近更新: 2024年1月8日

适应症

试验速览

暂无简介。

•1. Aged between 18-45 years; or 65-80 years
•2. Free from cardiovascular disease.
•3. Body mass index (BMI) <35
•4. Free from any signs or symptoms of fever or upper respiratory tract infections.
•5. Free from any musculoskeletal injuries or other conditions that would restrict the individual's ability to perform exercise safely.
•6. Non-smoker

•1. Previous diagnosis of myocardial infarction, stroke or angina.
•2. Vaccination for SARS-COV-2 within the past 1 month or scheduled SARS-COV-2 booster vaccine within the timeline of the trial.
•3. Signs and symptoms of fever or respiratory infection within the past 2 weeks.
•4. Body mass index (BMI) >35
•5. Osteoporosis - bone mineral density (t-score) < -2.5
•6. Severe depression, anxiety and/or stress according to the DASS; or diagnosis of psychotic disorder.
•7. Currently taking medication for cancer or immunological disorder.
•8. A musculoskeletal injury that inhibits the individual's ability to perform exercise safely.
•9. Evidence of substance abuse (e.g. pharmaceuticals, alcohol or other narcotics)

发起方

niversity of Southern Queensland